REQUEST A DEMO
Total
USD $0.00
Search more companies

Dolnoslaskie Centrum Onkologii, Pulmonologii I Hematologii (Poland)

Main Activities: General Medical and Surgical Hospitals
Full name: Dolnoslaskie Centrum Onkologii, Pulmonologii I Hematologii Profile Updated: May 09, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Polish Download a sample report

Lower Silesia Oncology Center is a company specializing in cancer research and clinical treatment, with a focus on cancer prevention and early detection programs. It offers modern systemic treatment of malignant tumors and operates a Gynecological Innovation Centre for female genital tumors. The company also has its own laboratory for testing the presence of the SARS-CoV-2 virus.

Headquarters
Ul. Pl. Ludwika Hirszfelda 12
Wroclaw; Dolnoslaskie; Postal Code: 53-413

Contact Details: Purchase the Dolnoslaskie Centrum Onkologii, Pulmonologii I Hematologii report to view the information.

Website: http://www.dco.com.pl

Basic Information
Total Employees:
Purchase the Dolnoslaskie Centrum Onkologii, Pulmonologii I Hematologii report to view the information.
Outstanding Shares:
Purchase the Dolnoslaskie Centrum Onkologii, Pulmonologii I Hematologii report to view the information.
Financial Auditors:
Purchase the Dolnoslaskie Centrum Onkologii, Pulmonologii I Hematologii report to view the information.
Incorporation Date:
February 05, 2002
Key Executives
Purchase this report to view the information.
Kierownik Publicznego Zakladu Opieki Zdrowotnej
Company Performance
Financial values in the chart are available after Dolnoslaskie Centrum Onkologii, Pulmonologii I Hematologii report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
6.35%
Total operating revenue
5.01%
Operating profit (EBIT)
-593.19%
EBITDA
N/A
Net Profit (Loss) for the Period
-735.76%
Total assets
-2.24%
Total equity
-1.19%
Operating Profit Margin (ROS)
-6.65%
Net Profit Margin
-6.76%
Return on Equity (ROE)
-11.46%
Quick Ratio
-0.34%
Cash Ratio
-0.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?